Ketone bodies, the products of fat metabolism, are a source of energy for the brain and are
available even when glucose supplies are inadequate (such as with severe carbohydrate …

INTRODUCTION The ketogenic diet (KD) is an intriguing therapeutic candidate for
Alzheimer's disease (AD) given its protective effects against metabolic dysregulation and …

Ketone bodies have potential disease-modifying activity that represent a novel therapeutic
approach for neurodegenerative diseases (NDD). The aim of this systematic review was to …

The ketogenic diet (KD) is a high-fat and low-carbohydrate diet with controlled amounts of
protein. The use of drastic caloric restriction or ultralow-carbohydrate diets increases the …

Introduction/aim The brain in Alzheimer's disease shows glucose hypometabolism but may
utilize ketones for energy production. Ketone levels can potentially be boosted through oral …

The ketogenic diet (KD) is a high-fat, low-carbohydrate and adequate-protein diet that has
gained popularity in recent years in the context of neurological diseases (NDs). The …

BACKGROUND: Metabolic disturbance is associated with risk for neurodegeneration, and
cerebral glucose hypometabolism is prominent in Alzheimer's disease (AD). Ketone …

There is currently no established therapy to treat or prevent Alzheimer's disease. The
ketogenic diet supplies an alternative cerebral metabolic fuel, with potential neuroprotective …

Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder that
primarily strikes the elderly. Studies in both humans and animal models have linked the …

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
(CNS) characterized by inflammation and neurodegeneration. Current research suggests …